CAPR · Company research
Capricor Therapeutics Inc (CAPR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| CAPR Nov 2026 9.000 put (CAPR261113P00009000) Stock Historical Prices & Data - Yahoo! Finance Canada | CAPR Nov 2026 9.000 put (CAPR261113P00009000) Stock Historical Prices & Data Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| CAPR Nov 2026 13.000 call (CAPR261113C00013000) Stock Price, News, Quote & History - Yahoo! Finance Canada | CAPR Nov 2026 13.000 call (CAPR261113C00013000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Voting power over 1.67M Capricor (CAPR) shares is shared by three reporting parties. - Stock Titan | Voting power over 1.67M Capricor (CAPR) shares is shared by three reporting parties. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| CAPR Stock Climbs On FDA’s Three-Month Deramiocel Extension — HC Wainwright Sticks To Neutral, Flags High Rejection Risk - Stocktwits | CAPR Stock Climbs On FDA’s Three-Month Deramiocel Extension — HC Wainwright Sticks To Neutral, Flags High Rejection Risk Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| Why Did CAPR Stock Jump 20% After-Hours Today? - Stocktwits | Why Did CAPR Stock Jump 20% After-Hours Today? Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| CAPR Stock On Track For Worst Day Ever — Analysts Divided On Deramiocel’s Approval Probability After FDA Documents Paint ‘Ugly Picture’ - Stocktwits | CAPR Stock On Track For Worst Day Ever — Analysts Divided On Deramiocel’s Approval Probability After FDA Documents Paint ‘Ugly Picture’ Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| This Analyst Slashed CAPR Stock’s Target By 86% – But, Retail Bulls Say Setup Offers An Attractive Risk-Reward - Stocktwits | This Analyst Slashed CAPR Stock’s Target By 86% – But, Retail Bulls Say Setup Offers An Attractive Risk-Reward Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy - Slideshow (NASDAQ:CAPR) 2026-10-13 - Seeking Alpha | Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy - Slideshow (NASDAQ:CAPR) 2026-10-13 Seeking Alpha | View source ↗ | Seeking Alpha | Oct 13, 2026 | neutral | 0 | 0.6 |
| CAPR Oct 2026 9.000 put (CAPR261009P00009000) Stock Price, News, Quote & History - Yahoo! Finance Canada | CAPR Oct 2026 9.000 put (CAPR261009P00009000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading - Stocktwits | MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus — These FDA Decisions Could Shape August Trading Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Analysts Expect Breakeven For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Before Long - Simply Wall Street | Analysts Expect Breakeven For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Before Long Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| Why did CAPR, LKQ, PSKY Stocks Plunge To 52-Week Lows Today? - Stocktwits | Why did CAPR, LKQ, PSKY Stocks Plunge To 52-Week Lows Today? Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| CAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - Stocktwits | CAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Investor Nets 94% Gain on Capricor Therapeutics (CAPR) Weekly Ca - GuruFocus | Investor Nets 94% Gain on Capricor Therapeutics (CAPR) Weekly Ca GuruFocus | View source ↗ | GuruFocus | Oct 7, 2026 | neutral | 0 | 0.6 |
| What's Going On With Capricor Therapeutics Stock Monday? - Benzinga | What's Going On With Capricor Therapeutics Stock Monday? Benzinga | View source ↗ | Benzinga | Oct 5, 2026 | neutral | 0 | 0.6 |
| Capricor Therapeutics (CAPR) Shares Drop 10% Despite Positive Du - GuruFocus | Capricor Therapeutics (CAPR) Shares Drop 10% Despite Positive Du GuruFocus | View source ↗ | GuruFocus | Oct 5, 2026 | neutral | 0 | 0.6 |
| Capricor Therapeutics Stock Surges: What's Going On? - Benzinga | Capricor Therapeutics Stock Surges: What's Going On? Benzinga | View source ↗ | Benzinga | Sep 30, 2026 | neutral | 0 | 0.6 |
| CAPR Stock Jumps As Analysts Hike Price Targets Ahead FDA Call - StocksToTrade | CAPR Stock Jumps As Analysts Hike Price Targets Ahead FDA Call StocksToTrade | View source ↗ | StocksToTrade | Sep 30, 2026 | neutral | 0 | 0.6 |
| Capricor Therapeutics (CAPR) Stock Gets Fair Value Boost After Deramiocel Analyst Revisions - Yahoo Finance | Capricor Therapeutics (CAPR) Stock Gets Fair Value Boost After Deramiocel Analyst Revisions Yahoo Finance | View source ↗ | Yahoo Finance | Sep 23, 2026 | neutral | 0 | 0.6 |
| After a year on placebo, patients’ arm-function decline rate was 76% lower on treatment - Stock Titan | After a year on placebo, patients’ arm-function decline rate was 76% lower on treatment Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.